Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling

[1]  Anders B. Dohlman,et al.  A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors , 2022, Cell.

[2]  Austin D. Swafford,et al.  Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions , 2022, Cell.

[3]  S. Wong,et al.  Altered mycobiota signatures and enriched pathogenic Aspergillus rambellii are associated with colorectal cancer based on multi-cohort fecal metagenomic analyses. , 2022, Gastroenterology.

[4]  J. Gerber,et al.  Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. , 2022, Cell host & microbe.

[5]  B. McDonald,et al.  “Molding” immunity—modulation of mucosal and systemic immunity by the intestinal mycobiome in health and disease , 2022, Mucosal Immunology.

[6]  W. D. de Jonge,et al.  Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome , 2022, Scientific reports.

[7]  W. D. de Jonge,et al.  Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis , 2022, Microorganisms.

[8]  J. Weitkamp,et al.  Clinical impact of NEC-associated sepsis on outcomes in preterm infants , 2022, Pediatric Research.

[9]  K. Korpela,et al.  The Effect of Antibiotics on the Infant Gut Fungal Microbiota , 2022, Journal of fungi.

[10]  Irina Leonardi,et al.  Immune regulation by fungal strain diversity in inflammatory bowel disease , 2022, Nature.

[11]  R. Yantiss,et al.  Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity , 2022, Cell.

[12]  M. Wahlqvist,et al.  Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health , 2022, Gut.

[13]  E. Dempsey,et al.  Clinical implications of preterm infant gut microbiome development , 2021, Nature Microbiology.

[14]  P. Wilson,et al.  Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn’s Disease , 2021, Nature Microbiology.

[15]  E. Savarino,et al.  Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. , 2021, Gastroenterology.

[16]  D. Cavalieri,et al.  Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients , 2021, Applied Microbiology and Biotechnology.

[17]  R. Geha,et al.  Multi-kingdom ecological drivers of microbiota assembly in preterm infants , 2021, Nature.

[18]  Minhu Chen,et al.  Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review , 2021, Frontiers in Pediatrics.

[19]  A. Puel,et al.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies , 2021, Cell.

[20]  F. Shanahan,et al.  The fecal mycobiome in patients with Irritable Bowel Syndrome , 2021, Scientific reports.

[21]  S. Brunke,et al.  Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels , 2020, The ISME Journal.

[22]  P. Clarke,et al.  Preterm Infants Harbour a Rapidly Changing Mycobiota That Includes Candida Pathobionts , 2020, Journal of fungi.

[23]  M. Caplan,et al.  Defining necrotizing enterocolitis: current difficulties and future opportunities , 2020, Pediatric Research.

[24]  K. Pollard,et al.  Accurate and sensitive detection of microbial eukaryotes from metagenomic shotgun sequencing , 2020, bioRxiv.

[25]  X. Hou,et al.  Gut fungal dysbiosis and altered bacterial‐fungal interaction in patients with diarrhea‐predominant irritable bowel syndrome: An explorative study , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[26]  Richard J. A. Wilson,et al.  Intestinal fungi are causally implicated in microbiome assembly and immune development in mice , 2020, Nature Communications.

[27]  P. Savelkoul,et al.  Higher Prevalence of Bacteroides fragilis in Crohn’s Disease Exacerbations and Strain-Dependent Increase of Epithelial Resistance , 2020, bioRxiv.

[28]  J. Clemente,et al.  Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis. , 2020, Cell host & microbe.

[29]  S. Roberts,et al.  A systematic review and meta analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe. , 2020, Journal of Crohn's & colitis.

[30]  G. Núñez,et al.  Host–microbiota interactions in inflammatory bowel disease , 2020, Nature Reviews Immunology.

[31]  W. Lieb,et al.  Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species , 2019, Gut.

[32]  W. D. de Jonge,et al.  Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis. , 2019, Journal of hepatology.

[33]  Bangmao Wang,et al.  The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome , 2019, Front. Microbiol..

[34]  S. Rampelli,et al.  HumanMycobiomeScan: a new bioinformatics tool for the characterization of the fungal fraction in metagenomic samples , 2019, BMC Genomics.

[35]  H. Sokol,et al.  Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis , 2019, Gut.

[36]  R. V. van Lingen,et al.  The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care , 2019, Front. Cell. Infect. Microbiol..

[37]  S. Targan,et al.  Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models. , 2019, Cell host & microbe.

[38]  Joshua D. Nosanchuk,et al.  Candida parapsilosis: from Genes to the Bedside , 2019, Clinical Microbiology Reviews.

[39]  M. Hattori,et al.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis , 2019, Nature Microbiology.

[40]  M. Hung,et al.  The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota‐Mediated Expansion of Myeloid‐Derived Suppressor Cells , 2018, Immunity.

[41]  Ti-Cheng Chang,et al.  SYK‐CARD9 Signaling Axis Promotes Gut Fungi‐Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer , 2018, Immunity.

[42]  R. Gibbs,et al.  The gut mycobiome of the Human Microbiome Project healthy cohort , 2017, Microbiome.

[43]  W. D. de Jonge,et al.  Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats. , 2017, Gastroenterology.

[44]  K. Rudi,et al.  Early gut mycobiota and mother-offspring transfer , 2017, Microbiome.

[45]  M. Manns,et al.  Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. , 2017, Gastroenterology.

[46]  G. Thallinger,et al.  Critical Issues in Mycobiota Analysis , 2017, Front. Microbiol..

[47]  K. Korolev,et al.  Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn’s Disease , 2016, Journal of Crohn's & colitis.

[48]  O. Jousson,et al.  Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract , 2016, Front. Microbiol..

[49]  D. Drossman.  Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. , 2016, Gastroenterology.

[50]  G. Liguori,et al.  Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. , 2016, Journal of Crohn's & colitis.

[51]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[52]  Hugues Aschard,et al.  Fungal microbiota dysbiosis in IBD , 2016, Gut.

[53]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[54]  H. Hallen-Adams,et al.  The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective , 2015, Mycologia.

[55]  Eric Z. Chen,et al.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. , 2015, Cell host & microbe.

[56]  Jaehyoung Kim,et al.  Fungi inhabiting the healthy human gastrointestinal tract: a diverse and dynamic community , 2015 .

[57]  D. Underhill,et al.  Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study , 2015, PloS one.

[58]  E. El-Omar,et al.  The fungal microbiota of de-novo paediatric inflammatory bowel disease , 2015, Microbes and infection.

[59]  D. Knights,et al.  Complementary Amplicon-Based Genomic Approaches for the Study of Fungal Communities in Humans , 2015, PloS one.

[60]  Z. Bian,et al.  TOPIC HIGHLIGHT , 2014 .

[61]  W. Stremmel,et al.  Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis , 2014, BMC Infectious Diseases.

[62]  H. Daniel,et al.  On the reclassification of species assigned to Candida and other anamorphic ascomycetous yeast genera based on phylogenetic circumscription , 2014, Antonie van Leeuwenhoek.

[63]  M. Neurath,et al.  Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis , 2013, Hepatology.

[64]  A. Cheifetz.  Management of active Crohn disease. , 2013, JAMA.

[65]  J. Perry,et al.  Bacterial and fungal viability in the preterm gut: NEC and sepsis , 2013, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[66]  A. Masclee,et al.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[67]  M. Dubinsky,et al.  Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis , 2012, Science.

[68]  B. Poindexter,et al.  Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment , 2010, Pediatrics.

[69]  L. Hensgens,et al.  Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites , 2010, BMC Microbiology.

[70]  Pierre Taberlet,et al.  ITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biases , 2010, BMC Microbiology.

[71]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[72]  J. Colombel,et al.  Yeasts: Neglected Pathogens , 2010, Digestive Diseases.

[73]  J. Kelsen,et al.  Inflammatory bowel disease: the difference between children and adults. , 2008, Inflammatory bowel diseases.

[74]  A. Zhernakova,et al.  Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. , 2008, American journal of human genetics.

[75]  A. Schoepfer,et al.  Anti‐Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans , 2007, Inflammatory bowel diseases.

[76]  H. Geiss,et al.  Biliary candida infections in primary sclerosing cholangitis. , 2006, Journal of hepatology.

[77]  W. Stremmel,et al.  The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis , 2006, European journal of gastroenterology & hepatology.

[78]  E. Buescher,et al.  Distinctive Distribution of Pathogens Associated With Peritonitis in Neonates With Focal Intestinal Perforation Compared With Necrotizing Enterocolitis , 2005, Pediatrics.

[79]  H. Drummond,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.

[80]  P. Plotsky,et al.  Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[81]  L. Saiman,et al.  Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.

[82]  R. V. van Lingen,et al.  The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants , 2022, Microbiome research reports.